Global 3d Bioprinting Market overview by Size, Share, SWOT Analysis, Segmentation, Emerging Trends, Future Outlook, Applications, Insights, Profile, key Players, Future Outlook, PESTEL analysis with Regional Insights of North America, Asia-Pacific, Europe, and the Middle East & Africa, Forecast To 2023
Global 3d Bioprinting Market is expected to reach a projected valuation of USD 1,923.02 million by 2023. The 3D Bioprinting market is calculated to register a striking CAGR of 24.59% during the forecast period. It is reported that the growing demand for organ transplantation is expected to push the growth of the 3D Bioprinting Market. Also, rising occurrences of organ failure owing to accidents, diseases, and old age have created a massive gap for the functioning of organs. The emergence of 3D bioprinting can fill-in the gap by producing them on a massive scale.
Furthermore, the cost-effective nature of the technology is expected to drive the market demand as well. Opportunities related to the manufacturing of pills for the pharmaceutical sector and for producing prosthetics and implants is anticipated to augment the market too. The rising investment for R&D activities is expected to broaden the potential of the technology and subsequently the market growth.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/869
3d Bioprinting Market Competitive Landscape
The Global 3d Bioprinting Market holds several key and prominent players, including FUJIFILM Wako Automation Corporation (U.S.), Regenhu Ltd. (Switzerland), Cyfuse Biomedical K.K. (Japan), Organovo Holdings Inc. (U.S.), Stratasys Ltd. (U.S.), EnvisionTEC GmbH (Germany), Cellink AB (Sweden), Allevi (U.S.), Regenovo Biotechnology Co. Ltd. (China), Aspect Biosystems Ltd. (Canada), Nano3D Biosciences Inc. (U.S.), and Poietis (France).
March 25th, 2019, CD3D, a Poland-based 3D printer company, announced the launch of the largest open 3D bioprinting cluster in Europe. Located in Lodz, Poland, the cluster consists of 21 SKAFFOSYS bioprinter units. The units will be leveraged upon to pursue R&D activities in the biomedical arena.
March 22nd, 2019, Allevi, a Philly-based 3D bioprinting company, introduced the innovative Skin Bioink Kit. The kit needs to be used in conjunction with its 3D bioprinters to create skin patches. The launch of the product is aimed at allowing tissue engineers to design multi-layered skin patches that are similar to natural human skin.
3d Bioprinting Market Segmentation
The Global 3d bioprinting market segmentation is based
By technologies, the 3D bioprinting market includes magnetic
- 3D bioprinting
- inkjet 3D bioprinting
- laser-assisted bioprinting
- microextrusion bioprinting
The microextrusion bioprinting is expected to grow significantly during the forecast period. Additionally, Inkjet 3D bioprinting segment is also anticipated to hold a significant share of the market due to its compatibility with living cells.
By material, the 3D bioprinting market includes
- living cells
- extracellular matrices
The living cells segment hold a major portion of the share due to its manufacturing using in-air microfluidics. Hydrogels segment is too expected to garner high demand in the forthcoming years.
By application, the 3D bioprinting market divides into
- research applications
It is expected for the clinical applications segment to pose a higher market share due to the demand of organ transplantation.
By end-user, the market segments into pharmaceutical & biotechnology companies and research organization & academic institutes. Both the segments are expected to grow in numbers in the forthcoming years.
3d Bioprinting Market Regional Analysis
The geographical segmentation of the global 3D bioprinting market is focused upon regions like Asia Pacific, the Americas, Europe, and the Middle East & Africa.
As per the last conducted study in 2017, the Americas held the highest share of the market due to considerable increase in research & development activities, existence of a large patient pool, development of healthcare infrastructure, and increasing budget expenditure of healthcare in countries like the US and Canada.
The European region held the second position in the global standings in terms of market share. This is primarily due to the surging investment in 3D printing and a high demand in countries like the UK, France, and Germany. Additionally, increasing application of the 3D bioprinting technology in the cosmetic sector alongside the band on animal testing are key factors that can further push the market growth in this region.
The Asia Pacific region is expected to garner the highest growth percentage over the forecast period due to the developing healthcare industry in China and other emerging economies. Also, collaboration among leading companies to set-up units, and increasing funding for research and development activities are expected to push the growth of the region further.
Table Of Contents:
- Report Prologue
- Market Introduction
- Research Methodology
- Market Dynamics
- Market Factor Analysis
- Global Cardiac 3D Bioprinting Market By Technology
- Global Cardiac 3D Bioprinting Market By Material
- Global Cardiac 3D Bioprinting Market By Region
- Global Cardiac 3D Bioprinting Market By End User
- Competitive Landscape
- Company Profiles
- List of Tables
Browse Full Report Details at: https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312
Email: [email protected]